[Problems of hemostaseology in obstetrico-gynecologic research and clinical practice].
D000031:Abortion, Septic / Q000150:complications; D000925:Anticoagulants / Q000627:therapeutic use*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D001803:Blood Transfusion; D005260:Female; D005313:Fetal Death / Q000150:complications; D006176:Gynecology; D006487:Hemostasis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007744:Obstetric Labor Complications / Q000628:therapy; D009774:Obstetrics; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy; D013300:Streptokinase / Q000627:therapeutic use; D013923:Thromboembolism / Q000188:drug therapy; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D006493:Heparin; D013300:Streptokinase
Hämostaseologie-Probleme in der geburtshilflich-bynäkologischen Forschung und Klinik.